Ingalls & Snyder LLC Idexx Laboratories Inc Transaction History
Ingalls & Snyder LLC
- $2.55 Billion
- Q4 2024
A detailed history of Ingalls & Snyder LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 530 shares of IDXX stock, worth $227,963. This represents 0.01% of its overall portfolio holdings.
Number of Shares
530
Previous 530
-0.0%
Holding current value
$227,963
Previous $268,000
18.28%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding IDXX
# of Institutions
1,225Shares Held
73.5MCall Options Held
151KPut Options Held
312K-
Vanguard Group Inc Valley Forge, PA9.71MShares$4.18 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$4.13 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.64MShares$1.56 Billion0.06% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.66MShares$1.15 Billion4.78% of portfolio
-
Geode Capital Management, LLC Boston, MA2.3MShares$988 Million0.08% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $35.8B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...